Cleared Traditional

K220212 - BD Vacutainer Push Button Blood Collect...

K220212 is the FDA 510(k) clearance for BD Vacutainer Push Button Blood Collect... by Becton, Dickinson and Company. It is a Class 2 General Hospital device (product code JKA) cleared through the Traditional 510(k) pathway after a 422-day FDA review.

K220212 · Becton, Dickinson and Company · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
422d
Days
Class 2
Risk

K220212 is an FDA 510(k) clearance for the BD Vacutainer® Push Button Blood Collection Set, BD Vacutainer® Push Button B.... Classified as Tubes, Vials, Systems, Serum Separators, Blood Collection (product code JKA), Class II - Special Controls.

Submitted by Becton, Dickinson and Company (Franklin Lakes, US). The FDA issued a Cleared decision on March 24, 2023 after a review of 422 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 862.1675 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Becton, Dickinson and Company devices

Submission Details

510(k) Number K220212 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 26, 2022
Decision Date March 24, 2023
Days to Decision 422 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
293d slower than avg
Panel avg: 129d · This submission: 422d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1675
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 115
Devices cleared under the same product code (JKA) and FDA review panel - the closest regulatory comparables to K220212.
Unistik® ShieldLock, Unistik VacuFlip
K223854 · Owen Mumford, Ltd. · Jun 2023
K-SHIELD Zen (Model Numbers: PBMH/ PBMA/ PBM)
K230408 · Sb-Kawasumi Laboratories, Inc. · Jun 2023
Kurin Blood Culture Collection Set with Kurin Lock Technology
K220677 · Kurin, Inc. · Apr 2023
Blood Collection Needle (with/without Needle Holder)
K223323 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · Mar 2023
BD Vacutainer® Luer-Lok™ Access Device, BD Vacutainer® Blood Transfer Device
K222478 · Becton, Dickinson and Company · Mar 2023
Kawasumi Multiple Sample Adapter with Pre-Attached Holder (MBCH)
K223810 · Sb-Kawasumi Laboratories, Inc. · Feb 2023